In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-05-01
DOI
https://doi.org/10.7326/annals-25-01325-jc
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo

Darren Lau
Annals of Internal Medicine
Pharmacology and Obesity Treatment
article

In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo

Darren Lau
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(5)
University of Alberta (CA)
Zero hunger
Openalex Percentile: Top 89%
Pharmacology and Obesity Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In adults with overweight or obesity and without diabetes, GLP-1 RAs increase weight loss vs. placebo — Darren Lau · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS